UNSPSC 51391725: Mabuterol

This classification denotes a beta-adrenergic agonist with the molecular formula C13H18ClF3N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R4K19W6S7Q, chemically known as benzenemethanol, 4-amino-3-chloro-alpha-(((1,1-dimethylethyl)amino)methyl)-5-(trifluoromethyl)- but generally known as mabuterol, which bears US NIH Compound Identifier 3995. European Medicines Agency schedules Mabuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08631MIG.

UNSPSC 51391725 Mabuterol, a Commodity code, does not align with the actual procurement activity tagged under it in state and local government sourcing. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS posted June 30, 2026—solicits naloxone and safe drug deactivation systems for community health support, not mabuterol (a bronchodilator medication used in respiratory treatment). The mismatch suggests either a classification error in the county's tagging or a data-entry inconsistency in the source system. State and local procurement activity under this specific Commodity code shows no recent, relevant opportunities aligned with mabuterol as a pharmaceutical product line.

The single posted opportunity does not represent a meaningful market signal for mabuterol procurement. Seminole County's naloxone and drug deactivation systems buy (1,900 units of naloxone and 800 deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a two-year initial contract term with one-year renewal option) operates under a different product scope entirely. Without additional state and local solicitations tagged to this Commodity code that actually name or seek mabuterol, no geographic concentration, issuing-body pattern, or pricing trend can be identified. Firms considering this code should verify its application in their target jurisdictions' procurement systems before allocating business development resources.